<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Real-time quantitative polymerase chain reaction (qPCR) was used to quantify <z:mp ids='MP_0001799'>viral</z:mp> loads of human herpesviruses (HHVs) at diagnosis in 61 samples of malignant B cells: 21 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-CLL), 29 <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>) and 11 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM); control samples were blasts from 16 <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) and 24 blood or bone marrow samples from healthy donors </plain></SENT>
<SENT sid="1" pm="."><plain>The majority of samples from healthy donors and patients (<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, B-CLL or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, but not MM) was positive for EBV and contained &lt;100 ebv copies/100 ng dna. ebv loads were occasionally high (&gt;500 copies/100 ng DNA) in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> (2/16) and in B-CLL (2/21) samples </plain></SENT>
<SENT sid="2" pm="."><plain>The fractions of samples positive for HHV-8 and HHV-6A, less than 10% for MM patients, were high for adults with <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> (18.8% HHV-8+, 43.8% HHV-6A+) or B-CLL (28.6% HHV-8+, 52.4% HHV-6A+) </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e>, B-CLL and MM samples were rarely positive for HHV-6B and HHV-7 </plain></SENT>
<SENT sid="4" pm="."><plain>Lastly, 75% of <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> samples were positive for CMV, and CMV loads were significantly higher in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> samples than in MM, B-CLL or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> samples </plain></SENT>
<SENT sid="5" pm="."><plain>We also used PCR with consensus-degenerate hybrid oligonucleotide primers (CODEHOP) to look for novel HHVs in B cell samples: no sequence indicative of a new HHV was detected </plain></SENT>
<SENT sid="6" pm="."><plain>Altogether, the data indicate that the presence of multiple HHVs, including EBV and CMV at high loads, is not rare in <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> and B-CLL cell samples </plain></SENT>
<SENT sid="7" pm="."><plain>Future prospective studies should determine whether patients with high EBV/CMV loads at diagnosis in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples face a higher risk of delayed hematological recovery, virus-related complications or relapse </plain></SENT>
</text></document>